Literature DB >> 1400444

Purification and characterization of 7 alpha-hydroxy-4-cholesten-3-one 12 alpha-hydroxylase.

H Ishida1, M Noshiro, K Okuda, M J Coon.   

Abstract

The isoform of cytochrome P450 that catalyzes the 12 alpha-hydroxylation of 7 alpha-hydroxy-4-cholesten-3-one, an intermediate in the conversion of cholesterol to cholic acid, was purified to homogeneity from rabbit liver microsomes. The extent of purification in the various steps was judged by an assay involving high performance liquid chromatography. The purified enzyme showed a single band on SDS-polyacrylamide gel electrophoresis (M(r) = 50,000). The NH2-terminal amino acid sequence is as follows: Val-Leu-Trp-Gly-Leu-Leu-Gly-Ala-Leu-Leu-Met-Val-Met-Val-Gly-, which is different from that of any other P450s so far reported. The specific content of the enzyme was 13.3 nmol of cytochrome P450/mg of protein. Upon reconstitution with NADPH-cytochrome P450 reductase and cytochrome b5, the P450 enzyme showed a high activity of 12 alpha-hydroxylation with a turnover number of 36.6 min-1 at 37 degrees C. The omission of either cytochrome P450 or NADPH-cytochrome P450 reductase resulted in complete loss of activity, and the omission of cytochrome b5 resulted in 40% loss of activity. Antibodies prepared from mouse inhibited the 12 alpha-hydroxylase activity of rabbit liver microsomes about 90% and that of the rat liver microsomes 50%. The enzyme activity was not inhibited by other antibodies raised against other forms of P450 that catalyze different monooxygenation reactions toward xenobiotics or endogenous substrates. Anti-cytochrome b5 antibody inhibited the activity 40%, suggesting the functional role of this protein, and anti-reductase inhibited the activity almost completely. The microsomal enzyme activity was markedly elevated by starvation or streptozotocin administration to the animals. However, an immunoblotting experiment showed no correlation between the enzyme activity and the amount of protein, suggesting that post-translational modification may occur.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400444

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Chemical synthesis of 7-oxygenated 12α-hydroxy steroid derivatives to enable the biochemical characterization of cytochrome P450 8B1, the oxysterol 12α-hydroxylase enzyme implicated in cardiovascular health and obesity.

Authors:  Samuel D Offei; Hadi D Arman; Mirza Oais Baig; Lazaro S Chavez; Carlos A Paladini; Francis K Yoshimoto
Journal:  Steroids       Date:  2018-11-03       Impact factor: 2.668

2.  Human sterol 12a-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern.

Authors:  Jin Wang; Sinead Greene; Lennart C Eriksson; Björn Rozell; Eva Reihnér; Curt Einarsson; Gösta Eggertsen; Mats Gåfvels
Journal:  Histochem Cell Biol       Date:  2005-05-13       Impact factor: 4.304

3.  A synthesis of a rationally designed inhibitor of cytochrome P450 8B1, a therapeutic target to treat obesity.

Authors:  Eunhee Chung; Samuel D Offei; U-Ter Aondo Jia; Juan Estevez; Yessenia Perez; Hadi D Arman; Francis K Yoshimoto
Journal:  Steroids       Date:  2021-12-27       Impact factor: 2.668

4.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 5.  Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies.

Authors:  Alyssa Kriegermeier; Richard Green
Journal:  Front Med (Lausanne)       Date:  2020-05-05

Review 6.  The influence of biological sex and sex hormones on bile acid synthesis and cholesterol homeostasis.

Authors:  Taylor Phelps; Erin Snyder; Erin Rodriguez; Hailey Child; Pamela Harvey
Journal:  Biol Sex Differ       Date:  2019-11-27       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.